Freestone Grove Partners »

Zenas Biopharma shares owned by Freestone Grove Partners

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by Freestone Grove Partners from 13F filings

Historical chart of Freestone Grove Partners investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Freestone Grove Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $25 1 25.00

More positions owned by Freestone Grove Partners

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Us Bancorp Com New (USB)
Raytheon Technologies Corp (RTX)
Ge Aerospace Com New (GE)
Crane Company Common Stock (CR)
American Intl Group Com New (AIG)
Snowflake Com Shs (SNOW)
Fortune Brands (FBIN)
Johnson & Johnson (JNJ)
Abbott Laboratories (ABT)
Axis Cap Hldgs SHS (AXS)
Keurig Dr Pepper (KDP)
Microsoft Corporation (MSFT)

View all positions for Freestone Grove Partners

Top funds holding Zenas Biopharma

FMR
Sr One Capital Management
NEA Management Company
Enavate Sciences GP
Federated Investors
BlackRock
Capital Research and Management Company - Division 3
Polar Capital Holdings
Royalty Pharma Sub-Manager
Fairmount Funds Management
NVP Associates
Wellington Management Company
State Street Corporation
Vanguard Capital Management
Bank of America Corporation

View all funds holding Zenas Biopharma